Nav : 17.7929
Date : 02-Jul-2024
Average Aum : 9150.23
| Stock Name | Sector | Value Mn | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Quantity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 183.9 | 13.29% | 0.00% | 14.85% (Mar 2024) | 13.06% (Oct 2023) | 1.26 L | -3.24 k |
| Cipla Ltd. | Pharmaceuticals | 100.2 | 7.24% | 0.00% | 8.14% (Aug 2023) | 6.57% (May 2023) | 69.23 k | -1.44 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 89.7 | 6.48% | 0.00% | 7.54% (Jul 2023) | 6.71% (Jan 2024) | 15.48 k | -0.24 k |
| Apollo Hospitals Enterprises Ltd. | Hospital | 78.3 | 5.66% | 0.00% | 6.73% (Jun 2023) | 5.72% (Apr 2024) | 13.41 k | -0.15 k |
| Max Healthcare Institute Ltd. | Hospital | 77.5 | 5.60% | 0.00% | 6.24% (Apr 2024) | 5.34% (Sep 2023) | 1.03 L | -1.66 k |
| ELI LILLY ORD SHS | Foreign equity | 72.8 | 5.26% | 0.00% | 5.11% (Mar 2024) | 3.24% (May 2023) | 1.07 k | -16.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 67 | 4.84% | 0.00% | 6.5% (May 2023) | 3.94% (Mar 2024) | 15.55 k | -0.54 k |
| Novo Nordisk A/S | Foreign equity | 48.6 | 3.51% | 0.00% | 0% (Jun 2024) | 0% (Jun 2024) | 4.31 k | 178.00 |
| Lupin Ltd. | Pharmaceuticals | 47.8 | 3.45% | 0.00% | 3.58% (Apr 2024) | 2.34% (May 2023) | 30.20 k | -0.46 k |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 41.5 | 3.00% | 0.00% | 3.15% (Nov 2023) | 2.47% (May 2023) | 35.00 k | -0.52 k |
| Johnson & Johnson | Foreign equity | 38.9 | 2.81% | 0.00% | 3.86% (Jul 2023) | 2.76% (Apr 2024) | 3.18 k | -41.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 35.9 | 2.59% | 0.00% | 2.65% (May 2023) | 2.31% (Aug 2023) | 13.32 k | -0.35 k |
| Merck & Co Inc Shs | Foreign equity | 35 | 2.53% | 0.00% | 2.72% (Mar 2024) | 2.29% (Sep 2023) | 3.35 k | -43.00 |
| AbbVie Inc | Foreign equity | 31.3 | 2.26% | 0.00% | 2.62% (Mar 2024) | 2.13% (Jun 2023) | 2.33 k | -31.00 |
| Fortis Healthcare Ltd. | Hospital | 29.9 | 2.16% | 0.00% | 2.06% (Dec 2023) | 1.77% (May 2023) | 62.98 k | 1.97 k |
| Thermo Fisher Scientific Inc | Foreign equity | 24.2 | 1.75% | 0.00% | 1.89% (Aug 2023) | 1.7% (Oct 2023) | 511.00 | -7.00 |
| Ipca Laboratories Ltd. | Pharmaceuticals | 21.8 | 1.58% | 0.00% | 1.81% (Nov 2023) | 1.36% (Jun 2023) | 18.93 k | 138.00 |
| NOVARTIS AG | Foreign equity | 21.7 | 1.57% | 0.00% | 1.94% (May 2023) | 1.58% (Apr 2024) | 2.53 k | -0.22 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 21.5 | 1.55% | 0.00% | 1.46% (Sep 2023) | 1.2% (May 2023) | 18.52 k | -0.49 k |
| Laurus Labs Ltd. | Pharmaceuticals | 19.8 | 1.43% | 0.00% | 1.73% (Aug 2023) | 1.31% (Mar 2024) | 47.22 k | 37.00 |
| Danaher Corporation | Foreign equity | 19.9 | 1.43% | 0.00% | 1.62% (Aug 2023) | 1.34% (Oct 2023) | 928.00 | -12.00 |
| Abbott Laboratories | Foreign equity | 19.5 | 1.41% | 0.00% | 1.73% (Feb 2024) | 1.46% (Apr 2024) | 2.29 k | -30.00 |
| Amgen | Foreign equity | 18 | 1.30% | 0.00% | 1.44% (Jan 2024) | 1.06% (Jun 2023) | 707.00 | -10.00 |
| Biocon Ltd. | Pharmaceuticals | 17.2 | 1.24% | 0.00% | 1.47% (May 2023) | 1.06% (Mar 2024) | 55.66 k | -0.65 k |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 16.4 | 1.18% | 0.00% | 1.27% (Apr 2024) | 1.04% (May 2023) | 9.23 k | -0.17 k |
| Syngene International Ltd. | Healthcare research, analytics & technology | 16.1 | 1.16% | 0.00% | 1.8% (Jun 2023) | 1.19% (Apr 2024) | 23.97 k | -0.26 k |
| Intuitive Surgical | Foreign equity | 15.6 | 1.13% | 0.00% | 1.15% (Mar 2024) | 0.9% (Sep 2023) | 465.00 | -7.00 |
| GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals | 13.9 | 1.00% | 0.00% | 0.85% (Feb 2024) | 0.58% (Jul 2023) | 5.30 k | -0.41 k |
| Gland Pharma Ltd. | Pharmaceuticals | 13.6 | 0.98% | 0.00% | 1.24% (Aug 2023) | 0% (May 2023) | 7.39 k | -0.37 k |
| Ajanta Pharma Limited | Pharmaceuticals | 13.5 | 0.97% | 0.00% | 1% (Nov 2023) | 0.72% (May 2023) | 5.78 k | -0.16 k |
| Global Health Ltd. | Hospital | 13.1 | 0.94% | 0.00% | 1.11% (Apr 2024) | 0% (May 2023) | 10.96 k | 111.00 |
| DR. LAL PATHLABS Ltd. | Healthcare service provider | 13 | 0.94% | 0.00% | 1.16% (Nov 2023) | 0.82% (Mar 2024) | 4.89 k | -0.17 k |
| Vertex Pharmaceuticals | Foreign equity | 12.9 | 0.93% | 0.00% | 0.96% (Jan 2024) | 0.78% (Sep 2023) | 341.00 | -5.00 |
| Stryker Corporation | Foreign equity | 12.8 | 0.93% | 0.00% | 1% (Mar 2024) | 0.82% (Sep 2023) | 452.00 | -7.00 |
| Medtronic Plc | Foreign equity | 11.9 | 0.86% | 0.00% | 1.05% (Jun 2023) | 0.85% (Apr 2024) | 1.76 k | -23.00 |
| Narayana Hrudayalaya Ltd. | Hospital | 11.2 | 0.81% | 0.00% | 1% (Nov 2023) | 0.87% (Apr 2024) | 9.45 k | -0.13 k |
| Sanofi India Ltd. | Pharmaceuticals | 9.2 | 0.67% | 0.00% | 0.78% (May 2023) | 0.63% (Mar 2024) | 1.07 k | -18.00 |
| Gilead Sciences | Foreign equity | 8.8 | 0.64% | 0.00% | 0.97% (Oct 2023) | 0.64% (Apr 2024) | 1.65 k | -20.00 |
| Suven Pharmaceuticals Ltd. | Pharmaceuticals | 8.4 | 0.60% | 0.00% | 0.74% (Oct 2023) | 0.61% (Feb 2024) | 13.52 k | -0.20 k |
| Pfizer Ltd. | Pharmaceuticals | 8.3 | 0.60% | 0.00% | 0.74% (May 2023) | 0.5% (Jan 2024) | 1.79 k | -55.00 |
| Becton Dickinson and Co | Foreign equity | 7.4 | 0.53% | 0.00% | 0.71% (Oct 2023) | 0.54% (Apr 2024) | 383.00 | -5.00 |
| Moderna Inc | Foreign equity | 5.1 | 0.37% | 0.00% | 0.39% (May 2023) | 0.23% (Nov 2023) | 428.00 | -7.00 |
| Iqvia Holdings | Foreign equity | 4.4 | 0.32% | 0.00% | 0.38% (Dec 2023) | 0.32% (Sep 2023) | 241.00 | -3.00 |
| Agilent Technologies Inc | Foreign equity | 4.2 | 0.30% | 0.00% | 0.37% (Dec 2023) | 0.29% (Sep 2023) | 387.00 | -6.00 |
| ILLUMINA | Foreign equity | 1.8 | 0.13% | 0.00% | 0.29% (May 2023) | 0.15% (Nov 2023) | 210.00 | -3.00 |
